Production (Stage)
Proto Script Pharmaceutical Corp.
PSCR
$0.0003
$0.000.00%
OTC PK
| 09/30/2017 | 06/30/2017 | 03/31/2017 | 12/31/2016 | 09/30/2016 | |
|---|---|---|---|---|---|
| Net Income | 14.70% | 34.26% | 93.04% | -7,264,300.00% | 100.15% |
| Total Depreciation and Amortization | 18.18% | 10.00% | 33.33% | 25.00% | 0.00% |
| Total Amortization of Deferred Charges | 1.10% | 57.45% | -- | -- | -- |
| Total Other Non-Cash Items | 413.07% | -118.90% | -97.64% | -- | -- |
| Change in Net Operating Assets | -65.42% | 155.19% | -86.82% | 1,207.58% | -149.50% |
| Cash from Operations | 76.79% | 51.30% | -625.67% | 207.07% | -385.07% |
| Capital Expenditure | 94.83% | -23.40% | 22.95% | -306.67% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 94.83% | -23.40% | 22.95% | -306.67% | -- |
| Total Debt Issued | 186.21% | -97.35% | 1,163.11% | -201.31% | 376.56% |
| Total Debt Repaid | -- | 200.00% | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | -58.50% | -78.35% | 997.09% | -201.31% | 263.98% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 100.00% | -206.62% | 2,400.00% | 78.50% | -105.77% |